Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Comparison of influenza vaccine effectiveness using different methods of case detection: clinician-ordered rapid antigen tests vs. active surveillance and testing with real-time reverse-transcriptase polymerase chain reaction (rRT-PCR).

Coleman LA, Kieke B, Irving S, Shay DK, Vandermause M, Lindstrom S, Belongia EA.

Vaccine. 2011 Jan 10;29(3):387-90. doi: 10.1016/j.vaccine.2010.10.082. Epub 2010 Nov 21.

PMID:
21095253
2.

Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results.

Belongia EA, Kieke BA, Donahue JG, Coleman LA, Irving SA, Meece JK, Vandermause M, Lindstrom S, Gargiullo P, Shay DK.

Vaccine. 2011 Sep 2;29(38):6558-63. doi: 10.1016/j.vaccine.2011.07.002. Epub 2011 Jul 19.

PMID:
21767593
3.

Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008.

Fielding JE, Grant KA, Papadakis G, Kelly HA.

BMC Infect Dis. 2011 Jun 14;11:170. doi: 10.1186/1471-2334-11-170.

4.

A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.

Skowronski DM, Janjua NZ, De Serres G, Winter AL, Dickinson JA, Gardy JL, Gubbay J, Fonseca K, Charest H, Crowcroft NS, Fradet MD, Bastien N, Li Y, Krajden M, Sabaiduc S, Petric M.

Clin Infect Dis. 2012 Aug;55(3):332-42. doi: 10.1093/cid/cis431. Epub 2012 Apr 26.

PMID:
22539661
5.

Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.

Belongia EA, Kieke BA, Donahue JG, Greenlee RT, Balish A, Foust A, Lindstrom S, Shay DK; Marshfield Influenza Study Group..

J Infect Dis. 2009 Jan 15;199(2):159-67. doi: 10.1086/595861.

PMID:
19086915
6.

Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.

Janjua NZ, Skowronski DM, De Serres G, Dickinson J, Crowcroft NS, Taylor M, Winter AL, Hottes TS, Fonseca K, Charest H, Drews SJ, Sabaiduc S, Bastien N, Li Y, Gardy JL, Petric M.

J Infect Dis. 2012 Jun 15;205(12):1858-68. doi: 10.1093/infdis/jis283. Epub 2012 Apr 9.

PMID:
22492921
7.

Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12.

Castilla J, Martínez-Baz I, Martínez-Artola V, Reina G, Pozo F, García Cenoz M, Guevara M, Morán J, Irisarri F, Arriazu M, Albéniz E, Ezpeleta C, Barricarte A; Primary Health Care Sentinel Network.; Network for Influenza Surveillance in Hospitals of Navarre..

Euro Surveill. 2013 Jan 31;18(5). pii: 20388.

8.

Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.

Skowronski DM, De Serres G, Dickinson J, Petric M, Mak A, Fonseca K, Kwindt TL, Chan T, Bastien N, Charest H, Li Y.

J Infect Dis. 2009 Jan 15;199(2):168-79. doi: 10.1086/595862.

PMID:
19086914
9.

Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea.

Song JY, Cheong HJ, Heo JY, Noh JY, Choi WS, Park DW, Lee J, Jeong HW, Kee SY, Kim WJ.

Vaccine. 2011 Feb 4;29(7):1395-8. doi: 10.1016/j.vaccine.2010.12.050. Epub 2011 Jan 1.

PMID:
21199701
10.

Mid-season influenza vaccine effectiveness 2011-2012: a Department of Defense Global, Laboratory-based, Influenza Surveillance System case-control study estimate.

MacIntosh VH, Tastad KJ, Eick-Cost AA.

Vaccine. 2013 Mar 25;31(13):1651-5. doi: 10.1016/j.vaccine.2013.01.022. Epub 2013 Feb 6.

PMID:
23395733
11.

Diagnosis of 2009 pandemic influenza A (pH1N1) and seasonal influenza using rapid influenza antigen tests, San Antonio, Texas, April-June 2009.

Lucas PM, Morgan OW, Gibbons TF, Guerrero AC, Maupin GM, Butler JL, Canas LC, Fonseca VP, Olsen SJ, MacIntosh VH.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S116-22. doi: 10.1093/cid/ciq027.

PMID:
21342882
12.

Clinical evaluation of rapid point-of-care testing for detection of novel influenza A (H1N1) virus in a population-based study in Spain.

de la Tabla VO, Antequera P, Masiá M, Ros P, Martin C, Gazquez G, Buñuel F, Sánchez V, Robledano C, Gutiérrez F.

Clin Microbiol Infect. 2010 Sep;16(9):1358-61. doi: 10.1111/j.1469-0691.2010.03159.x. Epub 2010 Feb 16.

13.

Diagnostic value of the rapid influenza antigen test for novel influenza A (H1N1).

Lee HM, Park HK, Hwang HS, Chun MY, Pai HJ, Oh SH, Kim DA.

Scand J Infect Dis. 2011 Jan;43(1):43-6. doi: 10.3109/00365548.2010.508463. Epub 2010 Aug 25. Erratum in: Scand J Infect Dis. 2011 Jul;43(6-7):560. Lee, Hang-Mee [corrected to Lee, Hyang-Mee].

PMID:
20735325
14.

Comparison of the performance of direct fluorescent antibody staining, a point-of-care rapid antigen test and virus isolation with that of RT-PCR for the detection of novel 2009 influenza A (H1N1) virus in respiratory specimens.

Ganzenmueller T, Kluba J, Hilfrich B, Puppe W, Verhagen W, Heim A, Schulz T, Henke-Gendo C.

J Med Microbiol. 2010 Jun;59(Pt 6):713-7. doi: 10.1099/jmm.0.017244-0. Epub 2010 Mar 4.

PMID:
20203216
15.

Sensitivity of rapid influenza antigen tests in the diagnosis of pandemic (H1N1)2009 compared with the standard rRT-PCR technique during the 2009 pandemic in Turkey.

Ciblak MA, Kanturvardar M, Asar S, Bozkaya E, Yenen OS, Badur S.

Scand J Infect Dis. 2010 Dec;42(11-12):902-5. doi: 10.3109/00365548.2010.502903. Epub 2010 Jul 22.

PMID:
20662619
16.

Evaluation of rapid influenza virus tests in patients with influenza-like illness in Thailand.

Makkoch J, Prachayangprecha S, Vichaiwattana P, Suwannakarn K, Theamboonlers A, Poovorawan Y.

Clin Lab. 2012;58(9-10):905-10.

PMID:
23163105
17.

Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study.

Jiménez-Jorge S, Savulescu C, Pozo F, de Mateo S, Casas I, Ledesma J, Larrauri A; cycEVA Study Team.; Spanish Influenza Sentinel Surveillance System..

Vaccine. 2012 May 21;30(24):3595-602. doi: 10.1016/j.vaccine.2012.03.048. Epub 2012 Mar 31.

PMID:
22472792
18.

Influenza vaccine effectiveness assessment through sentinel virological data in three post-pandemic seasons.

Torner N, Martínez A, Basile L, Marcos MA, Antón A, Mar Mosquera M, Isanta R, Cabezas C, Jané M, Domínguez A, Program Of Catalonia TP.

Hum Vaccin Immunother. 2015;11(1):225-30. doi: 10.4161/hv.36155. Epub 2014 Nov 1.

19.

Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.

Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric M, Li Y, Sebastian R, Chong M, Tam T, De Serres G.

Vaccine. 2007 Apr 12;25(15):2842-51. Epub 2006 Oct 16.

PMID:
17081662
20.

Rapid diagnosis of influenza: an evaluation of two commercially available RT-PCR assays.

Li M, Brenwald N, Bonigal S, Chana K, Osman H, Oppenheim B.

J Infect. 2012 Jul;65(1):60-3. doi: 10.1016/j.jinf.2012.04.003. Epub 2012 Apr 17.

PMID:
22522291

Supplemental Content

Support Center